Showing results (321-330 of 412) with videos related to

Sort By:
Pageof 42
The Lancet. Oncology|February 25, 2018
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human studyHoward A Burris, Ian W Flinn, Manish R Patel, et al.
Cell Reports|August 9, 2016
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AMLYue Zhao, Qi Liu, Pankaj Acharya, et al.
Blood|December 6, 2017
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemiaChristine Chen, David Siegel, Martin Gutierrez, et al.
Haematologica|January 22, 2026
Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge studyMikkael A Sekeres, Amer M Zeidan, Valeria Santini, et al.
British Journal of Haematology|June 17, 2025
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studiesMichael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E Ramsey, Dalton Greenwood, Susu Zhang, et al.
Pacing and Clinical Electrophysiology : PACE|May 24, 2023
Cardiac magnetic resonance imaging for left atrial appendage closure planningSapan Bhuta, Carolyn Cao, Justin A Pieper, et al.
Blood Advances|February 12, 2020
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignanciesMelissa A Fischer, Sharon Y Friedlander, Maria P Arrate, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.
Pageof 42